Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (1): 16-20. doi: 10.19723/j.issn.1671-167X.2019.01.004

Previous Articles     Next Articles

DNA cytometry of exfoliated cells in the diagnosis of oral potential malignant disorders

Yang LIU1,Yan GAO2,Xue-jie CHEN1,Hong HUA1,()   

  1. 1. Department of Oral Medicine, Beijing 100081, China
    2. Department of Oral and Maxillofacial Surgery, School of Stomatology, Shandong University, Jinan 250012, China
  • Received:2018-10-13 Online:2019-02-18 Published:2019-02-26
  • Contact: Hong HUA E-mail:honghua1968@aliyun.com
  • Supported by:
    Supported by the Program for New Clinical Techniques and Therapies of Peking University School and Hospital of Stomatology(PKUSSNCT-15A05)

RICH HTML

  

Abstract:

Objective: To evaluate the diagnostic efficiency of oral mucosa disease, especially oral squamous cell carcinoma (OSCC) and oral potential malignant disorders (OPMDs) by DNA cytometry compared with histopathological diagnosis, so as to find a convenient, simple and low-invasive method for screening and follow-up. Methods: 203 subjects with OSCC, OPMDs and other oral mucosa disease without dysplasia according to the inclusion criteria and exclusion criteria were recruited from Peking University School and Hospital of Stomatology. The mean age was (52.44±13.55) years, 98 males and 105 females. Brush biopsy was taken before scalpel biopsy at the same site. The brush biopsy sample was screened by moticytometer system for DNA cytometry after Feulgen stain, and histopathological examination were taken for the scalpel tissue. Data from DNA cytometry were used to calculate the parameters, such as sensitivity, specificity, positive and negative predictive values, odds ratios, Youden index (YI), positive and negative likelihood ratios, compared with the golden standard, histopathological diagnosis. DNA cytometry and histopathological diagnosis were performed back to back. Results: Totally, 42 OSCC and 4 tumor in situ (TIS), 39 oral leukoplakia (OLK) with dysplasia (17 mild dysplasia, 13 medium dysplasia and 9 severe dysplasia), 29 OLK with hyperplasia, 1 verrucous OLK, 83 oral lichen planus (OLP) and 5 inflammation were included in our research. We grouped the OSCC, TIS and dysplasia as the positive group and others without dysplasia as the negative group, the sensitivity of DNA cytometry was 79.07%, the specificity was 81.20%, and the diagnostic accuracy was 80.30%,We grouped the OSCC and TIS as the tumor group, OLP, OLK with hyperplasia and inflammation as the non-tumor group, The sensitivity of DNA cytometry in diagnosing OSCC and TIS was 95.65%, and the specificity was 81.2%, The diagnostic accuracy was 85.28%. positive predictive values 66.67%, negative predictive values 97.94%, ratio odds 95, positive likelihood ratio 5.09, negative likelihood ratio 0.05, and Youden index 0.77. For the dysplasia, we grouped the different dysplasia together as the dyaplasia group, OLP, OLK with hyperplasia and inflammation as the non-tumor group, the sensitivity of DNA cytometry in diagnosing dyaplasia is 60%, the specificity is 81.2%. The diagnostic accuracy is 75.8%, positive predictive values 52.17%, negative predictive values 85.59%, ratio odds 6.48,positive likelihood ratio 3.19, negative likelihood ratio 0.49, and Youden index 0.41. Conclusion: DNA cytometry is convenient and low-invasive, which can be used as an adjuvant method for screening the early OSCC and OPMDs, monitoring the prognosis of OSCC after surgery. Further large-scale and long period prospective studies are necessary to validate the better value of DNA cytometry.

Key words: DNA cytometry, Oral squamous cell carcinoma, Oral potential malignant disorders, Oral lichen planus, Oral leukoplakia

CLC Number: 

  • R739.8

Table 1

Description of the histopathological diagnosis and DNA cytometry"

Pathological diagnosis DNA cytometric Total
- ± +
OSCC 1 4 25 30
OSCC, early infiltration 1 2 9 12
TIS 0 2 2 4
OLK, hyperplasia 23 3 3 29
OLK, mild dysplasia 9 4 4 17
OLK, medium dysplasia 3 2 8 13
OLK, severe dysplasia 4 1 4 9
OLP 67 11 5 83
Inflammation 5 0 0 5
Verrucous OLK, active hyperplasia 0 0 1 1
Total 113 29 61 203

Table 2

Comparison of histopathology and DNA cytometry"

Items Histopathology + Histopathology - Total
DNA cytometry + 68 22 90
DNA cytometry - 18 95 113
Total 86 117 203

Table 3

Comparison of histopathology and DNA cytometry in OSCC and TIS"

Items Histopathology + Histopathology - Total
DNA cytometry + 44 22 66
DNA cytometry - 2 95 97
Total 46 117 163

Table 4

Comparison of histopathology and DNA cytometry in dysplasia"

Group Histopathology + Histopathology - total
DNA cytometry + 24 22 46
DNA cytometry - 16 95 111
Total 40 117 157

Table 5

The sensitivity, specificity and accuracy of DNA cytometry in different stages of dysplasia /%"

Group Sensitivity
(95%CI)
Specificity
(95%CI)
Accuracy
(95%CI)
Mild dysplasia 47.06
(23.86-71.47)
81.20
(72.7-87.6)
64.13
Medium dysplasia 76.92
(45.98-93.84)
81.20
(72.7-87.6)
79.06
Severe dysplasia 55.56
(22.65-84.66)
81.20
(72.7-87.6)
68.38
[1] Ferlay J, Soerjomataram I, Ervik M , et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base No. 11. Lyon, France: international agency for research on cancer 2013 [EB/OL]. ( 2018- 07- 30)[2018-09-30]. .
[2] Zheng CM, Ge MH, Zhang SS , et al. Oral cavity cancer incidence and mortality in China, 2010[J]. J Cancer Res Ther, 2015,11(Suppl 2):149-154.
doi: 10.4103/0973-1482.168176 pmid: 26506867
[3] Zeng H, Chen W, Zheng R , et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health, 2018,6(5):e555-e567.
doi: 10.1016/S2214-109X(18)30127-X pmid: 29653628
[4] Mello FW, Afp M, Dutra KL , et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis[J]. J Oral Pathol Med, 2018,47(7):633-640.
doi: 10.1111/jop.12726 pmid: 29738071
[5] Carrard VC, van der Waal I . A clinical diagnosis of oral leukoplakia; a guide for dentists[J]. Med Oral Patol Oral Cir Bucal, 2018,23(1):e59-e64.
doi: 10.4317/medoral.22292
[6] Smh A, Abushouk AI, Attia A , et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data[J]. Oral Oncol, 2017,68:92-102.
doi: 10.1016/j.oraloncology.2017.03.012 pmid: 28438300
[7] Mehanna HM, Rattay T, Smith J , et al. Treatment and follow-up of oral dysplasia: a systematic review and meta-analysis[J]. Head Neck, 2009,31(12):1600-1609.
doi: 10.1002/hed.21131 pmid: 19455705
[8] Haroske G, Baak JP, Danielsen H , et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry[J]. Anal Cell Pathol, 2001,23(2):89-95.
doi: 10.1155/2001/657642 pmid: 4618434
[9] Ma JM, Zhou TJ, Wang R , et al. Brush biopsy with DNA-image cytometry: a useful and noninvasive method for monitoring malignant transformation of potentially malignant oral disorders[J]. Eur Arch Otorhinolaryngol, 2014,271(12):3291-3295.
doi: 10.1007/s00405-014-2935-4 pmid: 24534896
[10] Warnakulasuriya KA, Johnson NW . Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer[J]. J Oral Pathol Med, 2010,25(3):97-103.
doi: 10.1111/j.1600-0714.1996.tb00201.x pmid: 9148038
[11] 曹婕, 刘宏伟, 刘晓松 , 等. 口腔黏膜微核细胞数与上皮异常增生病损癌变的关系[J]. 北京大学学报(医学版), 2011,43(4):600-602.
doi: 10.3969/j.issn.1671-167X.2011.04.027
[12] Awan KH, Morgan PR, Warnakulasuriya S . Evaluation of an autofluorescence based imaging system (VELscope TM) in the detection of oral potentially malignant disorders and benign keratoses [J]. Oral Oncol, 2011,47(4):274-277.
doi: 10.1016/j.oraloncology.2011.02.001 pmid: 21396880
[13] 魏世蓉, 王秋实, 杨新 , 等. 细胞DNA定量分析在尿脱落细胞学鉴别诊断中的应用[J]. 诊断病理学杂志, 2018,25(4):285-288.
doi: 10.3969/j.issn.1007-8096.2018.04.012
[14] 张喆, 孔令婷, 孙寒雪 , 等. 细胞DNA定量分析在宫颈病变筛查中的应用价值[J]. 中国医科大学学报, 2017,46(11):1013-1018.
doi: 10.12007/j.issn.0258-4646.2017.11.012
[15] Xiao X, Shi L, Li H , et al. DNA content status using brush biopsy with image cytometry correlated with staging of oral leukoplakia: a preliminary study[J]. Oral Oncol, 2015,51(1):59-63.
doi: 10.1016/j.oraloncology.2014.10.009 pmid: 25459158
[16] Liu Y, Li Y, Fu Y , et al. Quantitative prediction of oral cancer risk in patients with oral leukoplakia[J]. Oncotarget, 2017,8(28):46057-46064.
doi: 10.18632/oncotarget.17550 pmid: 5542248
[1] Xiaomeng REN,Kaiyi LI,Chunlei LI. Detection of molecular affecting sensitivity to local glucocorticoid therapy in oral lichen planus through transcriptome sequencing [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 32-38.
[2] Zheng-da ZHU,Yan GAO,Wen-xiu HE,Xin FANG,Yang LIU,Pan WEI,Zhi-min YAN,Hong HUA. Efficacy and safety of Nocardia rubra cell wall skeleton for the treatment of erosive oral lichen planus [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 964-969.
[3] Lei-zhen SU,Jie CHEN,Xian LI,Ping JI. Effects of salinomycin on proliferation and apoptosis of oral squamous cell carcinoma [J]. Journal of Peking University (Health Sciences), 2020, 52(5): 902-906.
[4] Chuan-si-bo TAO,Fan DONG,Dian-can WANG,Chuan-bin GUO. Diagnostic test for detection of cervical lymph node metastasis from oral squamous cell carcinoma via infrared thermal imaging [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 959-963.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!